Cencora, Inc.’s $5.5 Billion of Credit Facilities in Connection with its Acquisition of OneOncology

Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $5.5 billion of credit facilities made available to Cencora, Inc., as part of the financing transactions undertaken in connection with its acquisition of OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology. Cencora, Inc. is a leading global pharmaceutical sourcing and distribution services company. The credit facilities consisted of a $1.5 billion term loan facility, a $3.0 billion term loan facility and a $1.0 billion commitment increase under an existing revolving credit facility. The transaction closed on January 12, 2026.

The Cravath team included partner Tatiana Lapushchik and associates Nastassia Shcherbatsevich Li and Lindsey Corbett on banking matters; partner Ryan J. Patrone and associates Courtney T. Seager and R. Christian Dunn on capital markets matters; partner Arvind Ravichandran and associate Ruth Goldstein Schapiro on tax matters; and associates Anna Mikaelyan and Keanna N. Joseph on executive compensation and benefits matters. Elizabeth Jin also worked on banking matters, Han Wen Zhang worked on capital markets matters and Jonathan Jiang worked on tax matters.